Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 5, 2006, Pages 1113-1117

  Asero, Riccardo ^a   Tedeschi, Alberto ^b   Riboldi, Piersandro ^c,d   Cugno, Massimo ^b,d  

^a CLINICA SAN CARLO   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Chronic urticaria; histamine release; histamine releasing factors; plasma; skin tests

Indexed keywords

CITRATE SODIUM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; PROTHROMBIN; SERINE PROTEINASE; THROMBIN;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CHRONIC URTICARIA; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL; PERMEABILITY; PLASMA; PRICK TEST; PRIORITY JOURNAL; SCORING SYSTEM; SERUM; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PLASMA; PROTHROMBIN; SERUM; SKIN TESTS; THROMBIN; URTICARIA;

EID: 33646483033     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.12.1343     Document Type: Article

References (42)

1. Greaves M. Chronic urticaria. J Allergy Clin Immunol 105 (2000) 664-672
2. Grattan C.E., Wallington T.B., Warin R.P., Kennedy C.T., and Bradfield J.W. A serological mediator in chronic idiopathic urticaria: a clinical, immunological and histological evaluation. Br J Dermatol 114 (1986) 583-590
3. Gruber B.L., Baeza M.L., Marchese M.J., Agnello V., and Kaplan A.P. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 90 (1988) 213-217
4. Grattan C.E.H., Francis D.M., Hide M., and Greaves M.W. Detection of circulating histamine-releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 21 (1991) 695-704
5. Greaves M.W. Chronic urticaria. N Eng J Med 332 (1995) 1767-1772
6. Hide M., Francis D.M., Grattan C.E.H., Hakimi J., Kochan J.P., and Greaves M.W. Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria. N Eng J Med 328 (1993) 1599-1604
7. Tong L.J., Balakrishnan G., Kochan J.P., Kinet J.P., and Kaplan A.P. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 99 (1997) 461-465
8. Fiebiger E., Maurer D., Holub H., Reininger B., Hartmann B., Woisetschlager M., et al. Serum IgG autoantibodies directed against the alpha chain of FcεRI, a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?. J Clin Invest 96 (1995) 2606-2612
9. Zweiman B., Valenzano M., Atkins P.C., Tanus T., and Getsy J.A. Characteristics of histamine-releasing activity in patients with chronic idiopathic urticaria. J Allergy Clin Immunol 98 (1996) 89-98
10. Asero R., Tedeschi A., Lorini M., Salimbeni R., Zanoletti T., and Miadonna A. Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy 31 (2001) 1105-1110
11. Sabroe R.A., Francis D.M., Barr R.M., Kobza-Black A., and Greaves M.W. Anti-FcεRI autoantibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 102 (1998) 651-658
12. Ferrer M., Kinet J.P., and Kaplan A.P. Comparative studies of functional and binding assays for IgG and anti-FcεRI (alpha subunit) in chronic urticaria. J Allergy Clin Immunol 101 (1998) 672-676
13. Fagiolo U., Kricek F., Ruf C., Peserico A., Amadori A., and Cancian M. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 106 (2000) 567-572
14. Asero R., Lorini M., Chong S.U., Zuberbier T., and Tedeschi A. Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous serum skin test on human basophils and mastcells. Clin Exp Allergy 34 (2004) 1111-1114
15. Ferrer M., Nazakawa K., and Kaplan A.P. Complement-dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 104 (1999) 169-172
16. Kikuchi Y., and Kaplan A.P. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 107 (2001) 1056-1062
17. Kikuchi Y., and Kaplan A.P. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 109 (2002) 114-118
18. Grattan C.E., Hamon C.G., Cowan M.A., and Leeming R.J. Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria. Br J Dermatol 119 (1988) 179-183
19. Sabroe R.A., Grattan C.E., Francis D.M., Barr R.M., Kobza Black A., Greaves M.W., et al. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 140 (1999) 446-452
20. Kaplan A.P., Joseph K., Shibayama Y., Nakazawa Y., Ghebrehivet B., Reddigari S., et al. Bradykinin formation: plasma and tissue pathways and cellular interactions. In: Gallin J., and Snyderman R. (Eds). Inflammation: basic principles and clinical correlates. 3rd ed. (1999), Lippincott, Williams and Wilkins, Philadelphia 331-347
21. Ward P.A., and Hill J.H. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol 104 (1970) 535-543
22. Fagiolo U., Cancian M., Bertollo L., Peserico A., and Amadori A. Inhibitory effect of heparin on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 103 (1999) 1143-1147
23. Garcia J.G., Siflinger-Birnboim A., Bizios R., Del Vecchio P.J., Fenton II J.W., and Malik A.B. Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol 128 (1986) 96-104
24. DeMichele M.A., Moon D.G., Fenton II J.W., and Minnear F.L. Thrombin's enzymatic activity increases permeability of endothelial cell monolayers. J Appl Physiol 69 (1990) 1599-1606
25. Cugno M., Cicardi M., Bottasso B., Coppola R., Paonessa R., Mannucci P.M., et al. Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood 89 (1997) 3213-3218
26. Sheldon P.J., Oglevie S.B., and Kaplan L.A. Prolonged generalized urticarial reaction after percutaneous thrombin injection for treatment of a femoral artery pseudoaneurysm. J Vasc Interv Radiol 11 (2000) 759-761
27. Chua S.L., and Gibbs S. Chronic urticaria responding to subcutaneous heparin sodium. Br J Dermatol 153 (2005) 216-217
28. Parslew R., Pryce D., Ashworth J., and Friedmann P.S. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy 30 (2000) 1161-1165
29. Bauer K.A., and Weitz J.I. Laboratory markers of coagulation and fibrinolysis. In: Colman R.W., Hirsh J., Marder V.J., Clowes A.W., and George J.N. (Eds). Hemostasis and thrombosis: basic principles and clinical practice (2001), JB Lippincott, Philadelphia 1113-1129
30. Sabroe R.A., Fiebiger E., Francis D.M., Maurer D., Seed P.T., Grattan C.E.H., et al. Classification of anti-FcεRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 110 (2002) 492-499
31. Pelzer H., Schwart A., and Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 65 (1991) 153-159
32. Hursting M.J., Butman B.T., Steiner J.P., Moore B.M., Planck M.C., Szewczyk K.M., et al. Monoclonal antibodies specific for prothrombin fragment 1.2 and their used in a quantitative enzyme-linked immunosorbent assay. Clin Chem 39 (1993) 583-591
33. Goldsack N.R., Chambers R.C., Dabbagh K., and Laurent G.J. Thrombin. Int J Biochem Cell Biol 30 (1998) 641-649
34. Coughlin S.R. How the protease thrombin talks to cells. Proc Natl Acad Sci U S A 96 (1999) 11023-11027
35. Schaeffer R.C., Gong F., Bitrick M.S., and Smith T.L. Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms. Am J Physiol 264 (1993) 1798-1809
36. Cirino G., Cicala C., Bucci M.R., Sorrentino L., Maranganore J.M., and Stone S.R. Thrombin functions as an inflammatory mediator through activation of its receptors. J Exp Med 183 (1996) 821-827
37. Razin E., and Marx G. Thrombin-induced degranulation of cultured bone marrow-derived mast cells. J Immunol 133 (1984) 3282-3285
38. Vliagoftis H. Thrombin induces mast cell adhesion to fibronectin: evidence for the involvement of protease-activated receptor-1. J Immunol 169 (2002) 4551-4558
39. Kido H., Fukusen N., Katunuma N., Morita T., and Iwanaga S. Tryptase from rat mast cells converts bovine prothrombin to thrombin. Bioche Biophys Res Commun 132 (1985) 613-619
40. Bruhn H.D., Liebsch J., and Wagner C. Documentation of hypocoagulability by measurement of prothrombin fragment F 1 + 2 when introducing oral anticoagulant therapy. Thromb Res 68 (1992) 317-319
41. West G.B. Ethylene diamine tetraacetic acid and histamine release from rat mast cells. Int Arch Allergy Appl Immunol 68 (1982) 399-401
42. Nemeth A., Magyar P., Herceg R., and Huszti Z. Potassium-induced histamine release from mast cells and its inhibition by ketotifen. Agents Actions 20 (1987) 149-152